Trial Profile

A Phase 1 Study of LY2523355 in Patients With Solid Cancer

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 11 Jul 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Litronesib (Primary)
Indications Advanced breast cancer; Colorectal cancer; Gastric cancer; Haemangiosarcoma; Non-small cell lung cancer; Oesophageal cancer; Ovarian cancer; Small cell lung cancer; Solid tumours
Focus Adverse reactions
Sponsors Kyowa Hakko Kirin; Kyowa Kirin

Most Recent Events

23 Oct 2013 Results presented at the 25th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.
01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
11 Jun 2012 Planned number of patients added to 12 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com